喧嚣一时的“儿童退烧药事件”已渐趋沉寂,回顾事件主角——海南康芝药业股份有限公司在面对“尼美舒利”危机中所采取的一系列公关行为,笔者认为其偏离了医药企业公关的价值,远离了企业社会责任,因此它不能算是一次成功的危机公关。 The hustle and bustle of the “child anti-fever event” has become more silent, review the protagonist of the event - Hainan Kang Pharmaceutical Co., Ltd. in the face of “Nimesulide ” crisis in a series of public relations activities, I think it deviates from the value of the pharmaceutical company’s public relations, away from the corporate social responsibility, so it can not be regarded as a successful crisis PR.